The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of dexrazoxane on left ventricular function and treatment outcomes in patients with acute myeloid leukemia: A Children’s Oncology Group report.
 
Kelly D. Getz
No Relationships to Disclose
 
Lillian Sung
No Relationships to Disclose
 
Kasey Leger
No Relationships to Disclose
 
Todd Allen Alonzo
No Relationships to Disclose
 
Robert B Gerbing
No Relationships to Disclose
 
Todd Michael Cooper
Employment - Juno/Celgene (I)
Stock and Other Ownership Interests - Juno/Celgene (I)
 
Edward Kolb
No Relationships to Disclose
 
Alan S. Gamis
Consulting or Advisory Role - Novartis
 
Bonnie Ky
Consulting or Advisory Role - Bioinvent; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Gilead Sciences; Mateon Therapeutics; Roche; Roche
Research Funding - Pfizer; Roche
Patents, Royalties, Other Intellectual Property - Have a patent on the use of neuregulin-1b as a biomarker in heart failure; Pending patent application on the use of IgE as a biomarker of cardiotoxicity
 
Richard Aplenc
Honoraria - Sigma-Tau
Expert Testimony - Wiggin and Dana
Travel, Accommodations, Expenses - Sigma-Tau